Unknown

Dataset Information

Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey.


ABSTRACT:

Background

Understanding the waning of immunity after booster vaccinations is important to identify which immune-low populations should be prioritized.

Methods

We investigated longitudinal cellular and humoral immunity after the third vaccine dose in both high- and low-cellular and humoral immunity groups at the peak immunity phase after the booster vaccination in a large community-based cohort. Blood samples were collected from 1045 participants at peak (T1: median 54 days post-third dose) and decay (T2: median 145 days post-third dose) phases to assess IgG(S), neutralizing activity, and ELISpot responses. Participants were categorized into high/low ELISpot/IgG(S) groups at T1. Cellular and humoral responses were tracked for approximately five months after the third vaccina

SUBMITTER: Kobashi Y 

PROVIDER: S-EPMC11416657 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature